Market Capโ
$217.54M
Cash Runwayโ
24 mo
52W Highโ
$3.10
52W Lowโ
$0.6912
2Y Highโ
$25.00
-96.0% below 2Y high
RSI (14-day)โ
48.6
Neutral
Beta (1Y vs SPY)โ
1.31
Above Market
Next Earningsโ
Aug 3, 2026
in 44 days
Daily Short Vol %โ
50.1%
2026-06-18
Quantum-Si is building a semiconductor chip-based platform for single-molecule protein sequencing using quantum-detection technology. Its Platinum Pro system targets proteomics research; next-gen Proteus instrument targets late 2026 commercial launch.
Sector
Life Sciences Tools & Services
Industry
Life Sciences Tools & Services
Founded
2017
Headquarters
Guilford, CT
Shares Outstanding
217.8M
Quantum Division
https://www.quantum-si.com/technology/
Roadmap Target
Proteus commercial launch late 2026 (18+ amino acids, ~1,000ร throughput); 20 of 20 amino acids by 2027
Quantum-Si is NOT a quantum computing company. It uses quantum tunneling detection in a CMOS semiconductor chip for single-molecule protein sequencing (proteomics). Current product: Platinum Pro (launched Jan 2025, V4 kit detects 17 of 20 amino acids). Next-gen: Proteus instrument (late 2026 commercial launch target) โ 18+ amino acids at launch, tens of millions of peptides per experiment (vs. tens of thousands on Platinum Pro), ~90 min run time. Successful sequencing on integrated Proteus instruments (April 2026, KinetIQ Array dev kit, 17 amino acids); Early Access Program summer 2026.
Low Target
$1.00
+0.1%
Median Target
$2.50
+150.3%
High Target
$4.00
+300.4%
Analyst Recommendations
Recommendation Trend
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Current | 0 | 2 | 1 | 0 | 0 | 3 |
| 1 mo ago | 0 | 2 | 1 | 0 | 0 | 3 |
| 2 mo ago | 0 | 2 | 1 | 0 | 0 | 3 |
Current Ratings by Analyst (3 firms)
Source: Finnhub ยท most recent rating per firm
Consensus Target History
Solid = mean ยท dashed = high/low range ยท horizontal line = current price